Go Pro

Oscar Health (OSCR) Competitors

Oscar Health logo
$32.68 +1.90 (+6.17%)
Closing price 03:59 PM Eastern
Extended Trading
$32.67 0.00 (-0.01%)
As of 06:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

OSCR vs. CNC, MOH, HQY, ALHC, and CLOV

Should you buy Oscar Health stock or one of its competitors? Oscar Health's main competitors and comparable companies include Centene (CNC), Molina Healthcare (MOH), HealthEquity (HQY), Alignment Healthcare (ALHC), and Clover Health Investments (CLOV). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "managed healthcare" industry.

How does Oscar Health compare to Centene?

Centene (NYSE:CNC) and Oscar Health (NYSE:OSCR) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, media sentiment, analyst recommendations and earnings.

Oscar Health has a net margin of 3.60% compared to Centene's net margin of -2.51%. Oscar Health's return on equity of 44.96% beat Centene's return on equity.

Company Net Margins Return on Equity Return on Assets
Centene-2.51% 12.12% 3.20%
Oscar Health 3.60%44.96%7.73%

Oscar Health has lower revenue, but higher earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Oscar Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Centene$194.78B0.17-$6.67B-$10.44N/A
Oscar Health$11.70B0.84-$443.15M$1.4023.34

Centene has a beta of 1.08, indicating that its stock price is 8% more volatile than the broader market. Comparatively, Oscar Health has a beta of 2.36, indicating that its stock price is 136% more volatile than the broader market.

Centene presently has a consensus target price of $69.15, indicating a potential upside of 2.40%. Oscar Health has a consensus target price of $26.22, indicating a potential downside of 19.76%. Given Centene's higher possible upside, research analysts clearly believe Centene is more favorable than Oscar Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Centene
2 Sell rating(s)
9 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.40
Oscar Health
0 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.42

In the previous week, Oscar Health had 3 more articles in the media than Centene. MarketBeat recorded 18 mentions for Oscar Health and 15 mentions for Centene. Oscar Health's average media sentiment score of 0.99 beat Centene's score of 0.85 indicating that Oscar Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Centene
6 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Oscar Health
9 Very Positive mention(s)
4 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

93.6% of Centene shares are held by institutional investors. Comparatively, 75.7% of Oscar Health shares are held by institutional investors. 0.4% of Centene shares are held by company insiders. Comparatively, 22.6% of Oscar Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Oscar Health beats Centene on 12 of the 16 factors compared between the two stocks.

How does Oscar Health compare to Molina Healthcare?

Oscar Health (NYSE:OSCR) and Molina Healthcare (NYSE:MOH) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations, media sentiment and institutional ownership.

Oscar Health currently has a consensus target price of $26.22, suggesting a potential downside of 19.76%. Molina Healthcare has a consensus target price of $202.44, suggesting a potential downside of 4.62%. Given Molina Healthcare's higher probable upside, analysts clearly believe Molina Healthcare is more favorable than Oscar Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oscar Health
0 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.42
Molina Healthcare
2 Sell rating(s)
11 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.18

Oscar Health has a beta of 2.36, meaning that its share price is 136% more volatile than the broader market. Comparatively, Molina Healthcare has a beta of 0.75, meaning that its share price is 25% less volatile than the broader market.

In the previous week, Molina Healthcare had 6 more articles in the media than Oscar Health. MarketBeat recorded 24 mentions for Molina Healthcare and 18 mentions for Oscar Health. Molina Healthcare's average media sentiment score of 1.32 beat Oscar Health's score of 0.99 indicating that Molina Healthcare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Oscar Health
9 Very Positive mention(s)
4 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Molina Healthcare
13 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Molina Healthcare has higher revenue and earnings than Oscar Health. Molina Healthcare is trading at a lower price-to-earnings ratio than Oscar Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oscar Health$11.70B0.84-$443.15M$1.4023.34
Molina Healthcare$45.43B0.24$472M-$0.18N/A

75.7% of Oscar Health shares are held by institutional investors. Comparatively, 98.5% of Molina Healthcare shares are held by institutional investors. 22.6% of Oscar Health shares are held by insiders. Comparatively, 1.4% of Molina Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Oscar Health has a net margin of 3.60% compared to Molina Healthcare's net margin of -0.02%. Oscar Health's return on equity of 44.96% beat Molina Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Oscar Health3.60% 44.96% 7.73%
Molina Healthcare -0.02%3.73%0.97%

Summary

Oscar Health beats Molina Healthcare on 9 of the 15 factors compared between the two stocks.

How does Oscar Health compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and Oscar Health (NYSE:OSCR) are both mid-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment, risk and earnings.

HealthEquity currently has a consensus price target of $110.93, suggesting a potential upside of 5.92%. Oscar Health has a consensus price target of $26.22, suggesting a potential downside of 19.76%. Given HealthEquity's stronger consensus rating and higher probable upside, equities research analysts clearly believe HealthEquity is more favorable than Oscar Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
HealthEquity
1 Sell rating(s)
1 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.77
Oscar Health
0 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.42

In the previous week, Oscar Health had 6 more articles in the media than HealthEquity. MarketBeat recorded 18 mentions for Oscar Health and 12 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.02 beat Oscar Health's score of 0.99 indicating that HealthEquity is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
HealthEquity
6 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Oscar Health
9 Very Positive mention(s)
4 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

99.6% of HealthEquity shares are held by institutional investors. Comparatively, 75.7% of Oscar Health shares are held by institutional investors. 1.6% of HealthEquity shares are held by company insiders. Comparatively, 22.6% of Oscar Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

HealthEquity has a beta of 0.21, suggesting that its share price is 79% less volatile than the broader market. Comparatively, Oscar Health has a beta of 2.36, suggesting that its share price is 136% more volatile than the broader market.

HealthEquity has higher earnings, but lower revenue than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HealthEquity$1.31B6.67$215.20M$2.6739.22
Oscar Health$11.70B0.84-$443.15M$1.4023.34

HealthEquity has a net margin of 17.25% compared to Oscar Health's net margin of 3.60%. Oscar Health's return on equity of 44.96% beat HealthEquity's return on equity.

Company Net Margins Return on Equity Return on Assets
HealthEquity17.25% 14.75% 9.22%
Oscar Health 3.60%44.96%7.73%

Summary

HealthEquity beats Oscar Health on 11 of the 17 factors compared between the two stocks.

How does Oscar Health compare to Alignment Healthcare?

Oscar Health (NYSE:OSCR) and Alignment Healthcare (NASDAQ:ALHC) are both mid-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

Oscar Health presently has a consensus price target of $26.22, indicating a potential downside of 19.76%. Alignment Healthcare has a consensus price target of $23.60, indicating a potential upside of 69.05%. Given Alignment Healthcare's stronger consensus rating and higher possible upside, analysts plainly believe Alignment Healthcare is more favorable than Oscar Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oscar Health
0 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.42
Alignment Healthcare
0 Sell rating(s)
4 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.64

Alignment Healthcare has lower revenue, but higher earnings than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oscar Health$11.70B0.84-$443.15M$1.4023.34
Alignment Healthcare$3.95B0.73-$720K$0.1973.47

Oscar Health has a net margin of 3.60% compared to Alignment Healthcare's net margin of 0.89%. Oscar Health's return on equity of 44.96% beat Alignment Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Oscar Health3.60% 44.96% 7.73%
Alignment Healthcare 0.89%20.02%3.46%

Oscar Health has a beta of 2.36, indicating that its share price is 136% more volatile than the broader market. Comparatively, Alignment Healthcare has a beta of 1.1, indicating that its share price is 10% more volatile than the broader market.

75.7% of Oscar Health shares are held by institutional investors. Comparatively, 86.2% of Alignment Healthcare shares are held by institutional investors. 22.6% of Oscar Health shares are held by insiders. Comparatively, 5.2% of Alignment Healthcare shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Oscar Health had 1 more articles in the media than Alignment Healthcare. MarketBeat recorded 18 mentions for Oscar Health and 17 mentions for Alignment Healthcare. Oscar Health's average media sentiment score of 0.99 beat Alignment Healthcare's score of 0.36 indicating that Oscar Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Oscar Health
9 Very Positive mention(s)
4 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alignment Healthcare
4 Very Positive mention(s)
1 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral

Summary

Oscar Health beats Alignment Healthcare on 11 of the 17 factors compared between the two stocks.

How does Oscar Health compare to Clover Health Investments?

Clover Health Investments (NASDAQ:CLOV) and Oscar Health (NYSE:OSCR) are both mid-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, risk, institutional ownership, valuation, dividends, earnings and analyst recommendations.

19.8% of Clover Health Investments shares are held by institutional investors. Comparatively, 75.7% of Oscar Health shares are held by institutional investors. 23.5% of Clover Health Investments shares are held by insiders. Comparatively, 22.6% of Oscar Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Clover Health Investments has a beta of 2.47, suggesting that its stock price is 147% more volatile than the broader market. Comparatively, Oscar Health has a beta of 2.36, suggesting that its stock price is 136% more volatile than the broader market.

Oscar Health has a net margin of 3.60% compared to Clover Health Investments' net margin of -0.74%. Oscar Health's return on equity of 44.96% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Clover Health Investments-0.74% -4.35% -2.39%
Oscar Health 3.60%44.96%7.73%

In the previous week, Oscar Health had 5 more articles in the media than Clover Health Investments. MarketBeat recorded 18 mentions for Oscar Health and 13 mentions for Clover Health Investments. Oscar Health's average media sentiment score of 0.99 beat Clover Health Investments' score of 0.47 indicating that Oscar Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Clover Health Investments
4 Very Positive mention(s)
4 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Oscar Health
9 Very Positive mention(s)
4 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Clover Health Investments currently has a consensus price target of $4.33, suggesting a potential downside of 5.80%. Oscar Health has a consensus price target of $26.22, suggesting a potential downside of 19.76%. Given Clover Health Investments' higher probable upside, analysts plainly believe Clover Health Investments is more favorable than Oscar Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Oscar Health
0 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.42

Clover Health Investments has higher earnings, but lower revenue than Oscar Health. Clover Health Investments is trading at a lower price-to-earnings ratio than Oscar Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clover Health Investments$1.92B1.26-$85.55M-$0.05N/A
Oscar Health$11.70B0.84-$443.15M$1.4023.34

Summary

Oscar Health beats Clover Health Investments on 12 of the 17 factors compared between the two stocks.

Get Oscar Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for OSCR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OSCR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OSCR vs. The Competition

MetricOscar HealthHealthcare Providers & Services IndustryHealthcare SectorNYSE Exchange
Market Cap$9.85B$9.88B$6.97B$24.22B
Dividend YieldN/A2.55%2.58%3.69%
P/E Ratio23.3435.18269.8630.22
Price / Sales0.844.80602.2720.22
Price / CashN/A124.0070.5333.80
Price / Book9.935.3513.086.61
Net Income-$443.15M$309.96M$3.45B$1.06B
7 Day Performance17.00%0.21%1.12%0.55%
1 Month Performance5.30%0.60%1.79%3.13%
1 Year Performance122.53%20.36%67.69%18.71%

Oscar Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OSCR
Oscar Health
4.4166 of 5 stars
$32.68
+6.2%
$26.22
-19.8%
+104.7%$9.85B$11.70B23.342,305
CNC
Centene
3.2799 of 5 stars
$66.51
+1.1%
$68.58
+3.1%
+144.0%$32.86B$202.94BN/A61,100
MOH
Molina Healthcare
3.2187 of 5 stars
$198.90
+1.2%
$202.44
+1.8%
+27.8%$10.38B$44.52BN/A19,000
HQY
HealthEquity
4.0214 of 5 stars
$106.79
+2.1%
$110.93
+3.9%
+18.3%$8.93B$1.31B40.002,814
ALHC
Alignment Healthcare
4.576 of 5 stars
$13.78
-4.1%
$23.60
+71.3%
-8.8%$2.86B$3.95B72.531,849

Related Companies and Tools


This page (NYSE:OSCR) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners